L&G Healthcare Breakthrough UCITS ETF USD Accumulating ETF
IE00BK5BC677
L&G Healthcare Breakthrough UCITS ETF USD Accumulating ETF/ IE00BK5BC677 /
NAV07/06/2024 |
Var.-0.1073 |
Type of yield |
Focus sugli investimenti |
Società d'investimento |
11.4849USD |
-0.93% |
reinvestment |
Equity
Worldwide
|
LGIM Managers (EU) ▶ |
Investment strategy
The Fund is a passively managed exchange traded Fund that is a passively managed exchange traded Fund ("ETF") that aims to track the performance of the ROBO Global® Healthcare Technology and Innovation Index TR (the "Index"), subject to the deduction of the ongoing charges and other costs associated with operating the Fund.The Fund has a sustainable investment objective as it invests in companies which (i) contribute to social objectives, (ii) do not significantly harm any environmental or social objectives, and (iii) follow good governance practices.
Shares in this Share Class (the "Shares") are denominated in USD and can be bought and sold on stock exchanges by ordinary investors using an intermediary (e.g. a stockbroker). In normal circumstances, only Authorised Participants may buy and sell Shares directly with the Company. Authorised Participants may redeem their Shares on demand in accordance with the "Dealing Timetable" published on http://www.lgim.com.The Index is comprised of companies which are publically traded on various stock exchanges around the world that generate a proportion of their revenues from the healthcare technology industry. The industry is deemed to be comprised of the following nine subsectors: diagnostic, lab process automation, genomics, regenerative medicine, precision medicine, telehealth, data analytics, robotics and medical instruments. A company is only eligible for inclusion in the Index if it is of a sufficient size (determined by reference to the total market value of its shares) and it is sufficiently "liquid" (a measure of how actively its shares are traded on a daily basis).
Investment goal
The Fund is a passively managed exchange traded Fund that is a passively managed exchange traded Fund ("ETF") that aims to track the performance of the ROBO Global® Healthcare Technology and Innovation Index TR (the "Index"), subject to the deduction of the ongoing charges and other costs associated with operating the Fund.The Fund has a sustainable investment objective as it invests in companies which (i) contribute to social objectives, (ii) do not significantly harm any environmental or social objectives, and (iii) follow good governance practices.
Dati master
Type of yield: |
reinvestment |
Fondi Categoria: |
Equity |
Region: |
Worldwide |
Settore: |
ETF Stocks |
Benchmark: |
ROBO Global® Healthcare Technology and Innovation Index |
Business year start: |
01/07 |
Ultima distribuzione: |
- |
Banca depositaria: |
The Bank of New York Mellon SA/NV |
Domicilio del fondo: |
Ireland |
Permesso di distribuzione: |
Austria, Germany, Switzerland |
Gestore del fondo: |
- |
Volume del fondo: |
71.42 mill.
USD
|
Data di lancio: |
17/06/2019 |
Investment focus: |
- |
Condizioni
Sovrapprezzo emissione: |
0.00% |
Tassa amministrativa massima: |
0.49% |
Investimento minimo: |
1.00 USD |
Deposit fees: |
- |
Redemption charge: |
0.00% |
Prospetto semplificato: |
Download (Print version) |
Società d'investimento
Funds company: |
LGIM Managers (EU) |
Indirizzo: |
2 Dublin Landings, 1-W-131, Dublin |
Paese: |
Ireland |
Internet: |
www.lgim.com/ie/
|
Attività
Stocks |
|
99.85% |
Cash |
|
0.12% |
Altri |
|
0.03% |
Paesi
United States of America |
|
78.45% |
Switzerland |
|
5.47% |
Netherlands |
|
4.09% |
Jersey |
|
2.09% |
Italy |
|
1.96% |
Germany |
|
1.64% |
Luxembourg |
|
1.56% |
Canada |
|
1.27% |
China |
|
1.23% |
United Kingdom |
|
1.19% |
Japan |
|
0.90% |
Cash |
|
0.12% |
Altri |
|
0.03% |
Filiali
Healthcare |
|
95.97% |
IT/Telecommunication |
|
2.65% |
Consumer goods |
|
1.23% |
Cash |
|
0.12% |
Altri |
|
0.03% |